Weigao Group: Controlling Shareholder Lifts Stake to 46.61% After HK$101 Million H-Share Purchases

Bulletin Express07-14

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) reported that its controlling shareholder, Weigao Holding, has increased its position in the company’s H shares through open-market transactions.

Between 8 June 2026 and 14 July 2026, Weigao Holding acquired 15.60 million H shares, equivalent to 0.34% of both the company’s issued H-share capital and total share capital.

Aggregating these trades with purchases made since 13 May 2026, the controlling shareholder has accumulated 30.55 million H shares for a total consideration of approximately HK$101.00 million. This represents 0.68% of Weigao Group’s issued H shares and 0.67% of its overall issued share capital.

Following the latest transactions, Weigao Holding holds 2.13 billion H shares, translating to 47.11% of Weigao Group’s issued H shares and 46.61% of the company’s total issued shares.

The company stated that the additional investment underscores Weigao Holding’s confidence in Weigao Group’s long-term prospects. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1105540488?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 18:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105540488","market":"us","top_or_hot":-1,"title":"Weigao Group: Controlling Shareholder Lifts Stake to 46.61% After HK$101 Million H-Share Purchases","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) reported that its controlling shareholder, Weigao Holding, has increased its position in the company’s H shares through open-market transactions.</p>\n<p>Between 8 June 2026 and 14 July 2026, Weigao Holding acquired 15.60 million H shares, equivalent to 0.34% of both the company’s issued H-share capital and total share capital.</p>\n<p>Aggregating these trades with purchases made since 13 May 2026, the controlling shareholder has accumulated 30.55 million H shares for a total consideration of approximately HK$101.00 million. This represents 0.68% of Weigao Group’s issued H shares and 0.67% of its overall issued share capital.</p>\n<p>Following the latest transactions, Weigao Holding holds 2.13 billion H shares, translating to 47.11% of Weigao Group’s issued H shares and 46.61% of the company’s total issued shares.</p>\n<p>The company stated that the additional investment underscores Weigao Holding’s confidence in Weigao Group’s long-term prospects. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weigao Group: Controlling Shareholder Lifts Stake to 46.61% After HK$101 Million H-Share Purchases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeigao Group: Controlling Shareholder Lifts Stake to 46.61% After HK$101 Million H-Share Purchases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-14 18:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) reported that its controlling shareholder, Weigao Holding, has increased its position in the company’s H shares through open-market transactions.</p>\n<p>Between 8 June 2026 and 14 July 2026, Weigao Holding acquired 15.60 million H shares, equivalent to 0.34% of both the company’s issued H-share capital and total share capital.</p>\n<p>Aggregating these trades with purchases made since 13 May 2026, the controlling shareholder has accumulated 30.55 million H shares for a total consideration of approximately HK$101.00 million. This represents 0.68% of Weigao Group’s issued H shares and 0.67% of its overall issued share capital.</p>\n<p>Following the latest transactions, Weigao Holding holds 2.13 billion H shares, translating to 47.11% of Weigao Group’s issued H shares and 46.61% of the company’s total issued shares.</p>\n<p>The company stated that the additional investment underscores Weigao Holding’s confidence in Weigao Group’s long-term prospects. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1105540488","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105540488","pubTimestamp":1784025673,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) reported that its controlling shareholder, Weigao Holding, has increased its position in the company’s H shares through...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团：控股股东斥资1.01亿港元购买H股后持股46.61%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) reported that its controlling shareholder, Weigao Holding, has increased its position in the company’s H shares through open-market transactions.\nBetween 8 June 2026 and 14 July 2026, Weigao Holding acquired 15.60 million H shares, equivalent to 0.34% of both the company’s issued H-share capital and total share capital.\nAggregating these trades with purchases made since 13 May 2026, the controlling shareholder has accumulated 30.55 million H shares for a total consideration of approximately HK$101.00 million. This represents 0.68% of Weigao Group’s issued H shares and 0.67% of its overall issued share capital.\nFollowing the latest transactions, Weigao Holding holds 2.13 billion H shares, translating to 47.11% of Weigao Group’s issued H shares and 46.61% of the company’s total issued shares.\nThe company stated that the additional investment underscores Weigao Holding’s confidence in Weigao Group’s long-term prospects. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1105540488","isCrawlerRequest":true}